Deep Learning Reconstruction Shows Better Lung Nodule Detection for Ultra-Low-Dose Chest CT.
Jiang B, Li N, Shi X, Zhang S, Li J, de Bock GH, Vliegenthart R, Xie X.
Radiology. 2022 Apr;303(1):202-212. doi: 10.1148/radiol.210551. Epub 2022 Jan 18.
PMID:35040674
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial.
Gunther JR, Xu J, Bhutani MS, Strati P, Fang PQ, Wu SY, Dabaja BS, Dong W, Bhosale PR, Flowers CR, Nair R, Malpica Castillo L, Fayad L, Iyer SP, Parmer S, Wang M, Lee HJ, Samaniego F, Westin J, Ahmed S, Nze CC, Jain P, Neelapu SS, Rodriguez MA, Chihara D, Nastoupil LJ, Pinnix CC.
Lancet Haematol. 2024 Jul;11(7):e521-e529. doi: 10.1016/S2352-3026(24)00133-9. Epub 2024 Jun 3.
PMID:38843856
Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial.
Rodgers A, Salam A, Schutte AE, Cushman WC, de Silva HA, Di Tanna GL, Grobbee DE, Narkiewicz K, Ojji DB, Poulter NR, Schlaich MP, Oparil S, Spiering W, Williams B, Wright JT Jr, Lakshman P, Uluwattage W, Hay P, Pereira T, Amarasena N, Ranasinghe G, Gianacas C, Shanthakumar M, Liu X, Wang N, Gnanenthiran SR, Whelton PK; GMRx2 Investigators.
Lancet. 2024 Oct 19;404(10462):1536-1546. doi: 10.1016/S0140-6736(24)01744-6.
PMID:39426836
Low-dose and ultra-low-dose estradiol and dydrogesterone in postmenopause: an analysis by body mass index.
Ren M, Yu Q, Custodio MG, Simoncini T, Nappi RE, Tatarchuk T, Kahler E, Piha T, Stevenson JC.
Climacteric. 2025 Feb;28(1):21-27. doi: 10.1080/13697137.2024.2418497. Epub 2024 Oct 30.
PMID:39475406
Ultra-low dose radiotherapy in the management of low-grade orbital lymphomas.
Ultra-low-dose radiotherapy in the treatment of ocular adnexal lymphoma: a prospective study.
Yang X, Wang R, Yuan X, Yao S, Wang C, Cheng J.
Radiat Oncol. 2022 Dec 20;17(1):208. doi: 10.1186/s13014-022-02180-6.
PMID:36539787
Efficacy and safety of an ultra-low-dose 0.005 % estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause: A randomized double-blind placebo-controlled trial.
Muiños Fernández N, Martínez Salamanca JI, Pardo González de Quevedo JI, Diz Morales MP, Palomo Alameda L, Duce Tello S, González Béjar M, Rabanal Carrera A, Rosado Martín J, Noguera Vera L, Doyle Sanchez A, Rodríguez Mariblanca A, García Aguilar E.
Ultra-low dose rate brachytherapy (uLDR-BT) in treatment of patients with unfavorable intermediate-risk group prostate cancer - retrospective analysis.
Kluska A, Chyrek A, Burchardt WM, Włodarczyk M, Bielęda G, Chicheł A.